Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
Other matters subject to measures for electronic provision when convening the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
Notice of convocation of the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
FY2024 results briefing session
Watch video (external)
by JCR Pharmaceuticals
FY2024 results briefing session script
by JCR Pharmaceuticals
[Delayed] Notice of recognition of gain on deferred income taxes
by JCR Pharmaceuticals
FY2024 results briefing session material
by JCR Pharmaceuticals
Financial summary consolidated financial results for the year ended March 31, 2025 (FY2024) (Japanese standard)
by JCR Pharmaceuticals
Notice of distribution of retained earnings
by JCR Pharmaceuticals
JCR revises full-year consolidated forecast for FY2024
by JCR Pharmaceuticals
Notice of partial correction to “FY2024 third quarter consolidated financial results conference call material”
by JCR Pharmaceuticals
1
2
3
4
5
Privacy Preference Center
Privacy Preferences
